The Patent Finder
US

Imidazopyridine Compounds and Uses Thereof

US 9,937,185 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Bellus Health Cough Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Jan 31, 2034 · High confidence

Filed Sep 26, 2017 as application 15/716,410 · Granted Apr 10, 2018
Base term, 20 years from filing
Today
20 years from filing
2014 2034
Clock starts
Jan 31, 2014
Term ends
Jan 31, 2034
Granted
Apr 10, 2018
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,814,725, to Jan 31, 2034. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 31, 2014, when application PCT/CA2014/050062, the earliest non-provisional in its chain, was filed (this one was filed Sep 26, 2017)Jan 31, 2034High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,814,725)resolves to Jan 31, 2034, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 31, 2034High confidence

This family

US 9,598,409In force
Mar 2034
Mar 2034
US 9,814,725In force
Jan 2034
Jan 2034
US 9,937,185this patent
Jan 2034
Jan 2034
Application 15/906,230Abandoned
not computed
not computed
Application 16/375,773Abandoned
not computed
not computed
Application 16/736,599Abandoned
not computed
not computed
Application 17/005,238Abandoned
not computed
not computed
Application 17/225,753Abandoned
not computed
not computed
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 26, 2018
Reel 45034, frame 906
Buon, Christophe; Cantin, Louis-david; Hu, Yun-jin; Luo, Xuehong; Tomaszewski, Miroslaw JerzyAstraZeneca Canada Inc.Assignment of Assignor's Interest
Feb 26, 2018
Reel 45035, frame 356
AstraZeneca Canada Inc.AstraZeneca Canada ABAssignment of Assignor's Interest
Feb 26, 2018
Reel 45035, frame 418
AstraZeneca ABNeomed InstituteAssignment of Assignor's Interest
Dec 18, 2018
Reel 47949, frame 780
AstraZeneca Canada Inc.AstraZeneca ABCorrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 045035 Frame: 0356. Assignor(S) Hereby Confirms the Assignment.
Aug 24, 2022
Reel 60884, frame 13
Neomed InstituteBellus Health Cough Inc.Assignment of Assignor's Interest
Aug 9, 2023
Reel 64531, frame 830
Bellus Health Cough Inc.Bellus Health Inc.Merger
Aug 9, 2023
Reel 65117, frame 909
Bellus Health Inc.14245563 Canada Inc.Assignment of Assignor's Interest
Jan 19, 2024
Reel 66353, frame 331
14245563 Canada Inc.Id Biomedical Corporation of QuebecAssignment of Assignor's Interest
Jan 19, 2024
Reel 66353, frame 356
Id Biomedical Corporation of QuebecGlaxoSmithKline Intellectual Property (No.3) LimitedAssignment of Assignor's Interest
Apr 16, 2025
Reel 71351, frame 192
GlaxoSmithKline Intellectual Property (No.3) LimitedGlaxoSmithKline Intellectual Property (No.3) LimitedChange of Address

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited